IDXX - IDEXX Laboratories, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (3Y Monthly) 0.72
52-Week Change 328.25%
S&P500 52-Week Change 319.27%
52 Week High 3294.57
52 Week Low 3176.11
50-Day Moving Average 3261.81
200-Day Moving Average 3270.99

Share Statistics

Avg Vol (3 month) 3448.55k
Avg Vol (10 day) 3428.07k
Shares Outstanding 585.78M
Float 84.53M
% Held by Insiders 11.60%
% Held by Institutions 190.89%
Shares Short (Nov 15, 2019) 41.07M
Short Ratio (Nov 15, 2019) 42.26
Short % of Float (Nov 15, 2019) 41.41%
Short % of Shares Outstanding (Nov 15, 2019) 41.24%
Shares Short (prior month Oct 15, 2019) 41.14M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/2
Last Split Date 3Jun 16, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019


Profit Margin 17.99%
Operating Margin (ttm)23.50%

Management Effectiveness

Return on Assets (ttm)20.96%
Return on Equity (ttm)420.07%

Income Statement

Revenue (ttm)2.35B
Revenue Per Share (ttm)27.26
Quarterly Revenue Growth (yoy)11.00%
Gross Profit (ttm)1.24B
EBITDA 638.59M
Net Income Avi to Common (ttm)422.86M
Diluted EPS (ttm)4.82
Quarterly Earnings Growth (yoy)16.70%

Balance Sheet

Total Cash (mrq)104M
Total Cash Per Share (mrq)1.21
Total Debt (mrq)1.01B
Total Debt/Equity (mrq)496.88
Current Ratio (mrq)1.12
Book Value Per Share (mrq)2.36

Cash Flow Statement

Operating Cash Flow (ttm)439.39M
Levered Free Cash Flow (ttm)286.14M